Highlights of Vitreoretina

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Volume  17 (2024)
Volume  16 (2023)
Volume  15 (2022)
Volume  14 (2021)
Volume  13 (2020)
Volume  12 (2019)
Volume  11 (2018)
Volume  10 (2017)
Volume  9 (2016)
Volume  8 (2015)
Volume  7 (2014)
Volume  6 (2013)
Volume  5 (2012)
Volume  2 (2010)
Related articles

VOLUME 8 , ISSUE 2 ( June, 2015 ) > List of Articles

REVIEW ARTICLE

Uveítis en Enfermedades Sistémicas No-Infecciosas

Roham Soheilian

Citation Information : Soheilian R. Uveítis en Enfermedades Sistémicas No-Infecciosas. 2015; 8 (2):7-13.

DOI: 10.5005/hov-10102-08202

Published Online: 26-12-2020

Copyright Statement:  Copyright © 2015; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract
PDF Share
  1. Fernandez Espartero MC, Alejandre N, Diaz-Valle D. Sarcoidosis. En Diaz-Valle D, Méndez R, Benitez del Castillo JM. Actualización en el tratamiento de las uveítis. Ed. Sociedad Española de Oftalmología. Madrid 2007; 123-130.
  2. Crystal R. Sarcoidosis. En Harrison. Principios de Medicina Interna. Ed. Mc Graw-Hill: 1994; 1932-1938.
  3. Maña M. Sarcoidosis. Med Clin (Barc) 2001; 116: 307-311.
  4. Jabs DA, Johns CJ. Ocular involvement in chronic sarcoidosis. Am J Ophthalmol 1986; 102: 297-301.
  5. Adán A, Baget M, Llobet JM, Segura A, Marieges MT, Casaroli-Marano R. Uveítis como manifestación inicial de sarcoidosis. Estudio de 31 pacientes. Med Clin (Barc) 2004; 122: 748-752.
  6. Abad S, Meyssonier V, Allali J, Gouya H, Giraudet AL, Monnet D et al. Association of peripheral multifocal choroiditis with sarcoidosis: a study of thirty-seven patients. Arthritis Rheum 2004; 51: 974-982.
  7. Power WJ, Neves RA, Rodríguez A, Pedroza-Seres M, Foster CS. The value of combined serum angiotensina converting enzyme and gallium scan in the diagnosis of sarcoidosis. Ophthalmology 1995; 102: 2007-2012.
  8. Dev S, McCaluum RM, Jaffe GJ. Methotrexate treatment for sarcoid-associated panuveitis. Ophthalmology 1999 106: 111-118.
  9. Pritchard C, Nadarajah K. Tumour necrosis factor-alpha inhibitor treatment for sarcoidosis refractory to convenctional treatments. A reporto f five patients. Ann Rheum Dis 2004; 63: 318-320.
  10. Vogt A. Fruhzeitiges Ergaruen der Zilien und Bemerkungen uber den sogenaten plotzlichen Eintreitt dieser Veranderung. Klin Monatsbl Augenheilkd 1906; 44: 228-242.
  11. Koyanagi Y. Dysakusis, alopecia und poliosis bei schwerer Uveitis nicht traumatischen Ursprugs. Klin Monatsbl Augenheilkd 1929; 82: 194-211.
  12. Harada E. Acute diffuse choroiditis. Acta Soc Ophthalmol Jpn 1926; 30: 356-378.
  13. Read RW, Holland GN, Rao NA, Tabbara KF, Ohno S, Arellanes-Garcia L et al. Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclature. Am J Ophthalmol 2001; 131: 647-652.
  14. Andreoli CM, Foster CS. Vogt-Koyanagi-Harada disease. Int Ophthalmol Clin 2006; 46: 111-122.
  15. Bouchenaki N, Herbort CP. The contribution of indocyanine green angiography to the appraisal and management of Vogt-Koyanagi-Harada disease. Ophthalmology 2001; 108: 54-64.
  16. Bouchenaki N, Morisod L, Herbort CP. Vogt-Koyanagi-Harada syndrome: importance of rapid diagnosis and therapeutic intervention. Klin Monatsbl Augenheilkd 2000; 216: 290-294.
  17. Bykhovskaya I, Thorne JE, Kempen JH, Dunn JP, Jabs DA. Vogt-Koyanagi-Harada disease: Clinical Outcomes. Am J Ophthalmol 2005; 140: 674-678.
  18. Yamanaka E, Ohguro N, Yamamoto S, Nakagawa Y, Imoto Y, Tano Y. Evaluation of pulse corticosteroid therapy for Vogt-Koyanagi-Harada disease assessed by optical coherence tomography. Am J Ophthalmol 2002; 134: 454-456.
  19. Lai TY, Chan RP, Chan CK, Lam DS. Effects of the duration of initial oral corticosteroid treatment on the recurrence of inlamation in Vogt-Koyanagi-Harada disease. Eye 2008, Mar 28.
  20. Sasamoto Y, Ohno S, Matsuda H. Studies on corticosteroid therapy in Vogt-Koyanagi-Harada disease. Ophthalmologica 1990; 201: 162-167.
  21. Rubsamen PE, Gass JD: Vogt-Koyanagi-Harada syndrome. Clinical course, therapy and long-term visual outcome. Arch Ophthalmol 1991; 109: 682-687.
  22. Rajendram R, Evans M, Rao NA. Vogt-Koyanagi-Harada disease. Int Ophthalmol Clin 2005; 45: 115-134.
  23. Andrade RE, Muccioli C, Farah ME, Nussenblatt RB, Belfort R Jr. Intravitreal triamcinolone in the treatment of serous retinal detachment in Vogt-Koyanagi-Harada syndrome. Am J Ophthalmol 2004; 137: 572-574.
  24. Kim SJ, Yu HG. The use of low-dose azathioprine in patients with Vogt-Koyanagi-Harada disease. Ocul Immunol Inflamm 2007; 15: 381-387.
  25. Paredes I, Ahmed M, Foster CS. Immunomodulatory therapy for VKH patients as first line therapy. Ocul Immunol Inflamm 2006; 14: 87-90.
  26. Kahn P, Weiss M, Imundo LF, Levy DM. Favorable response to high-dose infliximab for refractory childhood uveitis. Ophthalmology 2006; 113: 860-864.
  27. Díaz Llopis M, Amselem L, Romero FJ, García-Delpech S, Hernández ML. Adalimumab therapy for Vogt-Koyanagi-Harada syndrome. Arch Soc Esp Oftalmol 2007; 82: 131-132.
  28. Hafler DA, Slavik JM, Anderson DE, O'connor KC, De Jager P, Beacher-Allan C. Multiple sclerosis. Immunol Rev 2005; 204: 208-231.
  29. Ruggieri M, Iannetti P, Polizzi A, Pavone L, Grimaldi LM, Italian Society of Paediatric Neurology Study Group on Childhood Multiple Sclerosis. Multiple sclerosis in children under 10 years of age. Neurol Sci 2004; 25 (Suppl 4): S326-S335.
  30. Jacobs DA, Galetta SL. Multiple sclerosis and the visual system. Ophthalmol Clin North Am 2004; 17: 265-273.
  31. Frohman EM, Frohman TC, Zee DS, et al. The neuro-ophthalmology of multiple sclerosis. Lancet Neurol 2005; 4: 111-121.
  32. Towler HM, Lightman S. Symptomatic intraocular inflammation in multiple sclerosis. Clin Experiment Ophthalmol 2000; 28: 97-102.
  33. Patte M, Rouher FN, Vernay D, Delaire JC, Bacin F. Proliferative retinal vasculitis and multiple sclerosis: a case report. J Fr Ophtalmol 2003; 26: 381-385.
  34. Smith JR, Rosenbaum JT. Neurological concomitants of uveitis. Br J Ophthalmol 2004; 88: 1498-1499.
  35. Zein G, Berta A, Foster CS. Multiple sclerosis-associated uveitis. Ocul Immunol Inflamm 2004; 12: 137-142.
  36. Biousse V, Trichet C, Bloch-Michel E, Roullet E. Multiple sclerosis associated with uveitis in two large clinic-based series. Neurology 1999; 52: 179-181.
  37. Perkins ES. Ocular toxoplasmosis. Br J Ophthalmol 1973;57(1):1-17.
  38. Burnett AJ, Shortt SG, Isaac-Renton J, et al. Multiple cases of acquired toxoplasmosis retinitis presenting in an outbreak. Ophthalmology 1998;105:1032-7.
  39. Holland GN, O'Conner GR. Ocular toxoplasmosis. In: Tasman W, ed. Duane's foundations of clinical ophthalmology. Philadelphia: Lippincott Williams & Wilkins, 2004.
  40. Gilbert RE, Stanford MR. Is ocular toxoplasmosis caused by prenatal or postnatal infection? Br J Ophthalmol 2000;84(2):224-6.
  41. Da Mata AP, Orifi ce F. Toxoplasmosis. In: Foster CF, Vitale AT, eds. Diagnosis and treatment of uveitis. Philadelphia: Saunders, 2002.
  42. Araujo F, Slifer T, Kim S. Chronic infection with Toxoplasma gondii does not prevent acute disease or colonization of the brain with tissue cysts following reinfection with different strains of the parasite. J Parasitol 1997;83(3):521-2.
  43. Isaac-Renton J, Bowie WR, King A, et al. Detection of Toxoplasma gondii oocysts in drinking water. Appl Environ Microbiol 1998;64(6):2278-80.
  44. Bosch-Driessen LE, Berendschot TT, Ongkosuwito JV, Rothova A. Ocular toxoplasmosis: clinical features and prognosis of 154 patients. Ophthalmology 2002;109:869-78.
  45. Stanford MR, See SE, Jones LV, Gilbert RE. Antibiotics for toxoplasmic retinochoroiditis: an evidence-based systematic review. Ophthalmology 2003;110:926-31; quiz 31-2.
  46. Soheilian M, Ramezani A, Azimzadeh A, et al. Randomized Trial of Intravitreal Clindamycin and Dexamethasone versus Pyrimethamine, Sulfadiazine, and Prednisolone in Treatment of Ocular Toxoplasmosis. Ophthalmology. 2011 Jan;118(1):134-41. Epub 2010 Aug 12.
  47. Holland GN. Reconsidering the pathogenesis of ocular toxo-plasmosis. Am J Ophthalmol 1999;128:502-5.
  48. Kishore K, Conway MD, Peyman GA. Intravitreal clindamycin and dexamethasone for toxoplasmic retinochoroiditis. Ophthalmic Surg Lasers 2001;32:183-92.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.